Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DEHYDROGENATION PROCESS
Document Type and Number:
WIPO Patent Application WO/2021/130057
Kind Code:
A1
Abstract:
The present invention relates to a new compound and the dehydrogenation of that compound to produce retinal.

Inventors:
BONRATH WERNER (CH)
MUELLER MARC-ANDRÉ (CH)
WUESTENBERG BETTINA (CH)
ZIMMERMANN VIKTOR (CH)
Application Number:
PCT/EP2020/086170
Publication Date:
July 01, 2021
Filing Date:
December 15, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DSM IP ASSETS BV (NL)
International Classes:
C07C403/14
Foreign References:
DE1254613B1967-11-23
Other References:
J. M. HOOVERS. S. STAHL, J. AM. CHEM. SOC., vol. 133, 2011, pages 16901 - 16910
Attorney, Agent or Firm:
KURT, Manfred (CH)
Download PDF:
Claims:
Claims

2. Dehydrogenation of the compound of formula (I) to the compound of formula (II) in the presence of at least one oxidative reactant of formula (III) wherein R1 is CN, Cl or F,

R2 is CN, Cl or F,

R3 is H, CHs, Cl or F, and R4 is H, CHs, Cl or F.

3. Dehydrogenation according to claim 2, wherein the oxidative reactant of formula (III) is chosen from the group consisting of the compounds of formula (Ilia), (I I lb) and (II lc)

(Ilia) (Hlb) and (lllc)

4. Dehydrogenation according to claim 2, wherein the oxidative reactant is the compound of formula (lllc)

5. Dehydrogenation according to anyone of the preceding claims 2 -4, wherein the amount the amount of the oxidative reactant of formula (III) goes from 0.5 mol-equivalent up to 5 mol-equivalent (in relation to compound of formula (I)).

6. Dehydrogenation according to anyone of the preceding claims 2 - 4, wherein the amount of the oxidative reactant of formula (III) goes from 0.5 mol-equivalent up to 3 mol-equivalent (in relation to compound of formula

(I))·

7. Dehydrogenation according to anyone of the preceding claims 2 - 6, wherein the process is carried out in the presence of at least one additive compound.

8. Dehydrogenation according to claim 7, wherein the additive compound is chosen from the group consisting of triethanolamine, pyridine, butylhydroxyltoluene, hydroquinone and triethoxyamine.

9. Dehydrogenation according to claims 7 or 8, wherein the additive compound is added in amount of 0.001 - 1 mol-equivalent (in relation to compound of formula (I)).

10. Dehydrogenation according to claims 7 or 8, wherein the additive compound is added in amount of 0.003 - 1 mol-equivalent (in relation to compound of formula (I)).

11. Dehydrogenation according to anyone of the preceding claims 2 -10, wherein the process is carried out in the presence of at least one inert solvent. 12. Dehydrogenation according to claim 11 , wherein the solvent is chosen from the group consisting aromatic hydrocarbon (i.e. benzene or toluene), ethyl acetate, THF, 2-methyltetrahydrofuran or 1, 4-dioxane.

13. Dehydrogenation according to anyone of the preceding claims 2 - 11, wherein the process is carried out at a temperature of from 0°C - 150 °C.

14. Dehydrogenation according to claims 7 or 8, wherein the process is carried out at a temperature of from 6°C - 150°C.

Description:
Dehydrogenation process

The present invention relates to a new compound, which is useful in the process of production of retinal (by dehydrogenation).

Retinal is an important compound, which can be used as such or it can be used to produce other derivatives of vitamin A (such as i.e. esters).

Due to its importance, there is always a need for a new and improved process to obtain retinal.

The goal of the present invention was to find a new and improved process to obtain retinal.

It was found that the newly found process allows to introduce the two double in one step under mild reaction conditions.

The new process uses the compound of formula (I) as starting material.

The compound of formula (I) can be in any of the 4 possible isomeric configurations.

The compound of formula (I) is a new compound.

Therefore, the present invention relates to the compound of formula (I)

The compound of formula (I) can be produced easily by processes known from the prior art. The synthesis of the compound of formula (I) is disclosed below.

As stated above the compound of formula (I) is a very suitable compound in the synthesis of retinal, which is the compound of formula (II)

As for the compound of formula (I), the compound of formula (II) can be in any isomeric configuration.

The new dehydrogenation process according to the present invention allows to introduce two double bonds in one step.

Therefore, the present invention also relates to the dehydrogenation (DH) of the following compound of formula (I) to the compound of formula (II) in the presence of at least one oxidative reactant of formula (III) wherein

R 1 is CN, Cl or F,

R 2 is CN, Cl or F,

R 3 is H, CHs, Cl or F, and R 4 is H, CHs, Cl or F.

Preferred oxidative reactants of formula (III) are those of the following formula (Ilia), (lllb) and (lllc):

(Ilia) (lllb) and (lllc) Very preferred is the compound of formula (lllc).

Therefore, the present invention relates to a dehydrogenation (DH1 ), which is dehydrogenation (DH), wherein the oxidative reactant is chosen from the group consisting of the compounds of formula (Ilia), (lllb) and (lllc)

Therefore, the present invention relates to a dehydrogenation (DH1 ), which is dehydrogenation (DH), wherein the oxidative reactant is the compound of formula (lllc)

The amount of the oxidative reactant of formula (III) used in the process according to the present invention can vary. The amount of the oxidative reactant of formula (III) usually goes from 0.5 mol-equivalent up to 5 mol-equivalent (in relation to compound of formula (I)). Preferably from 0.5 to 3 mol-equivalent (in relation to compound of formula (I)). Therefore, the present invention relates to a dehydrogenation (DH2), which is dehydrogenation (DH) or (DH1), wherein the amount of the oxidative reactant of formula (III) goes from 0.5 mol-equivalent up to 5 mol-equivalent (in relation to compound of formula (I)).

Therefore, the present invention relates to a dehydrogenation (DH2’), which is dehydrogenation (DH) or (DH1), wherein the amount of the oxidative reactant of formula (III) goes from 0.5 mol-equivalent up to 3 mol-equivalent (in relation to compound of formula (I)).

The process according to the present invention can also be carried out in the presence of at least one additive compound. This additive compound is usually chosen from the group consisting of triethanolamine, pyridine, butylhydroxyltoluene, hydroquinone and triethoxyamine.

The additive compound(s) is (are) added in amount of 0.001 - 1 mol-equivalent (in relation to compound of formula (I)), preferably 0.003- 1 mol-equivalent (in relation to compound of formula (I)).

Therefore, the present invention relates to a dehydrogenation (DH3), which is dehydrogenation (DH), (DH1), (DH2) or (DH2’), wherein the process is carried out in the presence of at least one additive compound.

Therefore, the present invention relates to a dehydrogenation (DH3’), which is dehydrogenation (DH), (DH1), (DH2) or (DH2’), wherein the additive compound is chosen from the group consisting of triethanolamine, pyridine, butylhydroxyltoluene, hydroquinone and triethoxyamine. Therefore, the present invention relates to a dehydrogenation (DH3”), which is dehydrogenation (DH), (DH1 ), (DH2) or (DH2’), wherein the additive compound is added in amount of 0.001 - 1 mol-equivalent (in relation to compound of formula

(I))·

Therefore, the present invention relates to a dehydrogenation (DH3’”), which is dehydrogenation (DH), (DH1 ), (DH2) or (DH2’), wherein the additive compound is added in amount of 0.003 - 1 mol-equivalent (in relation to compound of formula

(I))·

The reaction is usually carried out in an inert solvent. The solvent is usually an aprotic solvent such as aromatic hydrocarbon (i.e. benzene or toluene), ethyl acetate, THF, 2-methyltetrahydrofuran or 1 , 4-dioxane.

Therefore, the present invention relates to a dehydrogenation (DH4), which is dehydrogenation (DH), (DH1 ), (DH2), (DH2’), (DH3), (DH3’), (DH3”) or (DH3’”), wherein the process is carried out in the presence of at least one inert solvent.

Therefore, the present invention relates to a dehydrogenation (DH4’), which is dehydrogenation (DH4), wherein the solvent is a protic solvent.

Therefore, the present invention relates to a dehydrogenation (DH4”), which is dehydrogenation (DH4), wherein the solvent is chosen from the group consisting of aromatic hydrocarbon (i.e. benzene or toluene), ethyl acetate, THF, 2- methyltetrahydrofuran or 1 , 4-dioxane.

The process according to the present is usually carried out at elevated temperatures. Usually the process according to the present invention is carried out at a temperature of from 0°C - 150 °C, preferably from 30°C - 150°C, more preferred from 60°C - 150°C.

Therefore, the present invention relates to a dehydrogenation (DH5), which is dehydrogenation (DH), (DH1), (DH2), (DH2’), (DH3), (DH3’), (DH3”), (DH3’”), (DH4), (DH4’) or (DH4”), wherein the process is carried out at a temperature of from 0°C - 150 °C.

Therefore, the present invention relates to a dehydrogenation (DH5’), which is dehydrogenation (DH), (DH1), (DH2), (DH2’), (DH3), (DH3’), (DH3”), (DH3’”), (DH4), (DH4’) or (DH4”), wherein the process is carried out at a temperature of from 30°C - 150°C.

Therefore, the present invention relates to a dehydrogenation (DH5”), which is dehydrogenation (DH), (DH1), (DH2), (DH2’), (DH3), (DH3’), (DH3”), (DH3’”), (DH4), (DH4’) or (DH4”), wherein the process is carried out at a temperature of from 60°C - 150°C.

As stated above the new compound of formula (I) can be produced by using process known from the prior art.

A preferred way to produce the compound of formula (I) is the following:

The compound of formula (IV) is oxidized to the compound of formula (I): The same reaction conditions as in J. M. Hoover, S. S. Stahl, J. Am. Chem. Soc., 2011, 133, 16901-16910 are used.

The compound of formula (IV) can be obtain according to the following reaction scheme:

The following example serve to illustrate the invention. The temperature is given in °C and all percentages are related to the weight.

Examples

Example 1 :

(3E,6E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1 -en-1 -yl)nona-3,6-dienal (88 mg, 0.3 mmol; 1.0 eq), triethanolamine (3.1 mg, 0.02 mmol, 0.07 eq) and dry toluene (4.0 ml_) were placed in a dried two necked round bottom flask equipped with a magnetic stirrer and condenser under an argon atmospere. Solution of DDQ (71 mg, 0.3 mmol, 1.0 eq), in 1.0 ml_ dry toluene was added. The reaction was stirred at room temperature for 24 h. The reaction mixture was heated to 90°C and a solution of DDQ (73 mg, 0.3 mmol, 1.0 eq), in 1.0 ml_ dry toluene was added. The reaction was stirred at 90°C for 30 min. Subsequently cooled to room temperature and filtered over a glas fibre filter. All volatiles were evaporated under reduced pressure (40°C, 5 mbar) to obtain the product as dark red oil.